CUSTOMER STORY
$1.2 Million
In overhead costs will be saved each year
92%
Reduction in turnaround time for clinical studies
4X
Increase in prediction accuracy
Region: Global
Industry: Life Sciences and Pharmaceuticals
Department: IT
Company Background: IQVIA, formerly Quintiles and IMS Health, Inc., is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research.
Data Stack: AWS, Designer Cloud, Streamsets, Tableau.
Core Challenges
On any given day, IQVIA manages patient data for up to 70 different clinical studies run by government agencies, pharmaceutical companies and academic institutions. Under legacy tools and processes like SAS, copying this data into a single system from 250 unique vendor warehouses took days, while standardizing the data into FDA-compliant formats required 1 to 2 months. As the data generated from clinical trials came in at a faster rate and became increasingly non-identified and unstructured, IQVIA risked more significant delays, which would stall their clients’ progress.
How Designer Cloud Solved this Problem
IQVIA now operates upon a centralized data platform that includes Streamsets for data integration and Designer Cloud for data engineering. This new analytic stack has allowed IQVIA to drastically reduce its delivery times from 1 to 2 months down to 1 to 2 days. Instead of relying on in-house developers, Designer Cloud intuitive approach to data transformation has allowed IQVIA to scale its efforts through domain experts who are adept at spotting patterns and data quality issues. And even though patient data has grown larger and more complex, IQVIA has seen a 4X increase in prediction accuracy. As patient data continues to take on new forms, IQVIA can make simple adjustments to its Designer Cloud recipes while maintaining the same delivery speed.
BENEFITS OF USING ALTERYX
Faster Time to Value
With Designer Cloud, IQVIA reduced the turnaround time of executing analysis for their clients by 92%
Cost Savings
Once this process is adopted across all new and existing clinical trials, IQVIA will save $1.2 million a year by automating these analytics
Improved Accuracy
IQVIA has seen an increase in prediction accuracy by four times. This has helped IQVIA better match patients to trials and accelerate the pace of discovery
Company Background
IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare – and human health – forward.
Region: Global
Industry: Life Sciences and Pharmaceuticals
Department: IT
Company Background: IQVIA, formerly Quintiles and IMS Health, Inc., is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research.
Data Stack: AWS, Designer Cloud, Streamsets, Tableau.
Recommended Resources
Analyst Report
Nucleus Research – Alteryx Highlights AI and ROI at Inspire 2023
At Alteryx Inspire 2023, Alteryx announced various new and extended capabilities to
improve its value proposition for certain users or use-cases. This includes expanded cloud
platform experiences, cloud-based Location Intelligence for spatial analytics, integrated
generative AI capabilities with Alteryx AiDIN, and the Alteryx Maveryx user community.
Read Now
Customer Story
Growing a data-culture, naturally, at Roquette
A global leader in plant-based ingredients implemented Alteryx to enable strategic decision-making at scale.
Learn More
Customer Video
All In with Rufus
Tired of tedious work? Rufus too. See how he’s created a better day to day with automation.
Watch Now